CARGO Therapeutics, Inc. (CRGX)
NASDAQ: CRGX · IEX Real-Time Price · USD
15.83
-1.21 (-7.10%)
At close: Jul 19, 2024, 4:00 PM
15.76
-0.07 (-0.44%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
CARGO Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for CARGO Therapeutics stock have an average target of 30.83, with a low estimate of 23 and a high estimate of 37. The average target predicts an increase of 94.76% from the current stock price of 15.83.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CRGX stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 4 |
| Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 5 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $33 | Strong Buy | Initiates | $33 | +108.46% | Jul 22, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Initiates $28 | Strong Buy | Initiates | $28 | +76.88% | Jul 8, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $37 | Buy | Initiates | $37 | +133.73% | Jun 27, 2024 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $34 → $32 | Strong Buy | Reiterates | $34 → $32 | +102.15% | May 16, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $28 → $32 | Strong Buy | Maintains | $28 → $32 | +102.15% | Mar 22, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
1.28M
EPS This Year
-4.92
from -16.53
EPS Next Year
-5.41
from -4.92
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 5.3M | 192.7M | 323.0M | 393.8M |
| Avg | n/a | 1.3M | 108.9M | 248.7M | 380.9M |
| Low | n/a | n/a | 29.4M | 176.4M | 364.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 15,012.9% | 196.6% | 58.3% |
| Avg | - | - | 8,440.4% | 128.4% | 53.2% |
| Low | - | - | 2,205.9% | 62.0% | 46.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -4.52 | -4.47 | -3.97 |
| Avg | -4.92 | -5.41 | -4.63 |
| Low | -5.52 | -6.60 | -5.19 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.